Neurobehavioral Medicine Group #222 — Bloomfield Hills, Michigan

Neurobehavioral Medicine Group #222 is a clinical research site located in Bloomfield Hills, Michigan, United States 48302.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Neurobehavioral Medicine Group #222 has participated in 1 clinical trials.

Therapeutic areas: Neurobehavioral Disinhibition.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Neurobehavioral Medicine Group #222?

Neurobehavioral Medicine Group #222 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Neurobehavioral Medicine Group #222 conducted?

Neurobehavioral Medicine Group #222 has 1 clinical trials on record. Their work covers Neurobehavioral Disinhibition.

Is Neurobehavioral Medicine Group #222 accredited by Crixeo Health?

Neurobehavioral Medicine Group #222 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Neurobehavioral Medicine Group #222?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.